Combined drugIt has an analgesic, antipyretic, controversial action.

Paracetamol - Analgesic Antipyatik. Blocks CHA mainly in the CNS, affecting the centers of pain and thermoregulation; It has analgesic and antipyretic effect.

Sodium metamizol is an antipictic analgesic derivative of pyrazolone. It has a pronounced analgesic effect.

Caffeine - psychostimulator, improves the well-being of patients and reduces headache Vascular genesis (including migraine).

Phenobarbital - Barbiturate, increases the analgesic efficacy of sodium and paracetamol metamizole.

Codeine has an anesthetic effect due to the excitation of opioid receptors in various parts of the central nervous system, leading to the stimulation of the antinocyptive system and the change in the emotional perception of pain.

Pharmacokinetics

Pentalgin ® -icn pharmacokinet data data is not provided.

Form release

Tablets from white to white with a yellow or cream tint of color, double-screwed, in the form of a capsule with flat side surfaces, with a risk on one side and engraving "Pentalgin" - to another.

Auxiliary substances: Potato starch, povidone (polyvinylpyrrolidone low molecular weight medical), stearin acid, calcium stearate.

6 pcs. - Packaging cell contour (1) - packs cardboard.
6 pcs. - Packaging cell contour (2) - packs cardboard.
10 pieces. - Packaging cell contour (1) - packs cardboard.
10 pieces. - Packaging cell contour (2) - packs cardboard.
12 pcs. - Packaging cell contour (1) - packs cardboard.
12 pcs. - Packaging cell contour (2) - packs cardboard.
10 pieces. - Packaging cell contour (500) - cardboard boxes.
12 pcs. - Packaging cell contour (500) - cardboard boxes.
6 pcs. - Packaging cell contour (500) - cardboard boxes.

Dosage

Assign 1 tab. 1-3 times / day. Maximum daily dose - 4 tab.

The drug should not take more than 5 days as an anesthetic agent and more than 3 days as an antipyretic remedy without appointing and observing the doctor.

Overdose

Symptoms: nausea, vomiting, gastralgy, tachycardia, arrhythmia, oppression of the respiratory center.

Treatment: washing the stomach, the purpose of intestinal adsorbents, if necessary, the conduct of symptomatic therapy.

Interaction

With the simultaneous use of funds that have an inoperative effect on the central nervous system (including sedatives and tranquilizers) is likely to enhance the sedimentation of the sedative effect and the oppressive effect on the respiratory center. Enhances the effect of ethanol on a psychomotor reaction. Sodium metamizole reduces cyclosporine concentration.

Sodium metamizole, displacing oral hypoglycemic drugs due to protein, indirect anticoagulants, GKS and Indomethacin, increases their activity. Tricyclic antidepressants, contraceptive means for intake, allopurinol disturb the metamizole metamizole metabolism in the liver and increase its toxicity.

The simultaneous use of Pentalgin® -Iticn preparation with other non-constidium analgesics can lead to amplification of toxic effects.

Barbiturates, Phenylbutazone and other inductors of microsomal liver enzymes weaken the action of sodium metamizol.

Side effects

From the CNS: dizziness, drowsiness.

From side of cardio-vascular system: heartbeat, tachycardia.

From side digestive system: Nausea, vomiting, constipation.

From the side of the blood formation system: leukopenia, granulocyptopenia, agranulocytosis.

Allergic reactions: rash, itching, urticaria.

Others: With a long-term uncontrolled reception in high doses - addictive (weakening an anesthetic effect), drug addiction (codeine), hepatic and / or renal failure.

Indications

• pain syndrome of various genesis of weak and medium intensity (including arthralgia, myalgia, radiculitis, algodismenae, neuralgia, headache, toothache);
• walled diseases and conditions accompanied by feverish syndrome.

Contraindications

• severe liver failure;
• renal failure of severe;
• bronchial asthma;
• anemia, leukopenia;
• states accompanied by inhibition of breathing;
• card-brain hypertension;
• acute myocardial infarction;
• arrhythmias;
• glaucoma;
• alcoholic intoxication;
• deficiency of glucose-6-phosphate dehydrogenase;
• pregnancy;
• lactation period ( breastfeeding);
• childhood up to 12 years;
• increased sensitivity to the components of the drug.

Caution should be used the drug when peptic disease Stomach I. duodenal gut in the remission phase arterial hypertension, in elderly patients.

Features of application

Application in pregnancy and breastfeeding

Application is contraindicated during pregnancy and during lactation (breastfeeding).

Application with violations of liver function

Contraindication: Heavy liver failure.

Application with violations of the kidney function

Contraindication: renal failure of severe.

Application in children

Contraindication: children's age up to 12 years.

Application in elderly patients

Caution should be used the drug in elderly patients.

special instructions

With long-term (more than 1 week) treatment requires control of the picture of peripheral blood and functional state Liver.

When taking the drug Pentalgin ® -ICN, it is possible to change the results of doping control analyzes in athletes.

Reception of Pentalgin ® -icn makes it difficult to establish a diagnosis with acute abdominal pain syndrome.

In patients suffering from atopic bronchial asthma, Polinoses, there is an increased risk of developing hypersensitivity reactions.

Impact on the ability to driving vehicles and control mechanisms

When applying the drug, patients should refrain from potentially dangerous species Activities requiring increased attention and the speed of psychomotor reactions.

Pentalgin-ICN is a complex drug that has an antipyretic, as well as analgesic and contrasting effect. A preparation is produced in tablet and in capsules.

Tablets have white with cream or yellow color, as well as a bico form. Capsules have a flat side texture, on one side there is risk, to another - engraving Pentalgin.

Composition "Pentalgin-ICN"

In total, the package is one or two contour cells, in one of them there are six, ten, twelve pieces. The active ingredients in the composition of one tablet are:

• paracetamol;
• caffeine;
• sodium metamizol;
• phosphate Codeine;
• phenobarbital.

Additional substances are considered:

• potato starch;
• polyvinylpyrrolidone;
• octadecanic acid;
• calcium salt and stearic acid.

Sample Pentalgin-ICN recipe on Latin:

Rp: Tab. Pentalginum.

D.T.D: N 10 in TAB.

S: 1 tablet 2-3 times a day.

Pharmacological properties

The Pentalgin drug refers to the number of complex medicines that have an antipyretic, as well as an anesthetic and controversial impact, due to the properties of active substances:

• Paracetamol is considered an analgesic antipytic. It blocks cyclooxygenase, as a rule, in the central nervous system by influencing thermoregulation and pain. Paracetamol has an anesthetic and antipyretic effect.
• Sodium metamizole is considered to be a pyrazolone derivative, as well as an analgesic antipirector. This component has a pronounced painkillers.
• Caffeine acts as a psychostimulator. It lowers the intensity of the headache of vascular origin, and also helps improve well-being.
• Phenobarbital is considered to be barbituat. It increases the anesthetic effect of paracetamol and sodium metamizole.
• Codeine has an analgesic effect, which is due to the excitation of opioid nerve endings in different departments of the central nervous system, which leads to a change in the emotional perception of pain and activation of the antinocirtable system.

Indications

Pentalgin is prescribed with the following states:

1. Painful syndrome of weak or average intensity of various origin.
2. Artralgia (pain in the joints that appear in the absence of severe signs of defeat, but may precede a more serious disease).
3. Malgia (pathology for which pain in muscles is characteristic of the appearance of pain).
4. Radiculitis (inflammatory damage to nerve roots, which are included in intervertebral holes).
5. Algodismenorrhea (unpleasant pulling pain at the bottom of the abdomen and in the lower back before the occurrence of menstruation, which can last until the completion of critical days).
6. Neuralgia (damage to peripheral nerves, which is due to the attacks of pain in the innervation zone of any nerve).
7. Migraines (neurological disease for which constant strong and painful headaches are characterized in different parts heads).
8. Toothache.
9. Colds.

Contraindications

According to the instructions for use to Pentalgin-ICN, it is known that the drug has certain prohibitions, for example:

1. Liver and kidney disease.
2. The lack of a cytosolic enzyme (a disease that is inherited is characterized by a decrease in the activity of the cytosolic enzyme, which leads to increased destruction of red blood cells and anemia).
3. Alcoholic intoxication.
4. The disease is due to the suppression of breathing.
5. Leukopenia (pathological condition in which the number of leukocytes in the blood becomes less than the standard).
6. Bronchial asthma (chronic inflammatory damage to respiratory organs with the participation of various cell elements).
7. Anemia (a disease in which the amount of red blood cells and hemoglobin in the blood is reduced).
8. Myocardial infarction (source of ischemic necrosis of myocardium, which occurs subsequently acute disruption of coronary blood circulation).
9. Pregnancy.
10. Card-brain hypertension (pathological condition in which pressure is increasing inside the skull).
11. Breast-feeding.
12. Glaucoma (chronic pathological process of organs of vision, which is due to increasing intraocular pressure, as well as the appearance optical neuropathy and violations of vision).
13. Arrhythmia (pathology, which leads to a violation of the frequency, as well as the rhythm and sequence of excitation and reduction of the heart).
14. Age up to twelve years.
15. Arterial hypertension (steady increase in blood pressure).
16. Ulcerative lesion of the stomach and duodenum.
17. Elderly age.

Method and dosage

According to the instructions, Pentalgin-ICN is used orally on one tablet from one to three times a day, the maximum - to four pieces of tablets per day.

Without observing the Doctor, the drug as an antipyretic and analgesic means should not be used for longer than five days.

Adverse reactions

According to the instructions for applying to Pentalgin, it is known that negative phenomena may occur when incorrectly or uncontrolled dosage:

1. Tachycardia (view of arrhythmia characterized by the frequency of heart abbreviations of more than 90 shots per minute).
2. Heartbeat.
3. Drowsiness.
4. Dizziness.
5. Granulocyte (reduced concentration of granulocytes in peripheral blood).
6. Leukopenia (pathological process, in which the number of leukocytes in the blood becomes less than certain values).
7. Agranulocytosis (a disease for which the reduction in blood plasma levels is characterized).
8. Vomit urge.
9. Nausea.
10. Drug addiction.
11. Intestinal obstruction.
12. Rash on the skin.
13. The urticaria (a disease of allergic origin, which is characterized by the formation of blisters on the skin and on the mucous membranes).
14. Getting used.
15. Liver and kidney disease.

Treatment is aimed at reducing the absorption of active ingredients, an integrated therapy is carried out if necessary.

Features

When treating this drug, athletes may vary the results of doping research. When performing long therapy (from 7 days) it is important to control the functioning of the liver and the picture of peripheral blood. With sharp pain sensations The use of Pentalgin-ICN may impede diagnosis.

The probability of occurrence of increased sensitivity is higher in people with pollinozles and atopic bronchial asthma. During the use of a drug patient from driving and work, which requires speed of reactions and increased attention, it is necessary to refrain.

According to the instructions, Pentalgin during the "interesting situation" and breastfeeding is not appointed. Use medicine at the age of twelve years is prohibited.

Medicinal interaction

Pentalgin preparation has an overwhelming effect on the central nervous system An increase in the severity of the oppressive effect on the respiratory center and the soothing effect may occur.

Neopoidal painkillers increase toxic action. Ethanol Impact on the psychomotor reaction increases.

Analogs

Generic "Pentalgin-ICN" is considered:

1. "Sedalgin".
2. "Pentalgin".
3. "Sedal-M".
4. "Santoperalgin".

It is necessary to keep the drug in a place that is protected from light and moisture, at a temperature of up to twenty-five degrees. Place the medicine imposed away from children. Shelf life - thirty-six months. Recommended by the doctor's prescription.

/ Pentalgin-ICN

Pentalgin-ICN Pentalgin-ICN

Manufacturer

Farmstandart-Lexed, Russia

Pharmacological group

Analgesic

Active substance

metamizole sodium, codeine, phenobarbital, caffeine, paracetamol

"Pentalgin-ICN" is effective drug, which has a strong analgesic and antipyretic effect, relieves painful syndrome of various etiology. Pentalgin-ICN is particularly effective in severe pains, including migraine. Can be applied walled diseases. The pharmacies are discharged from pharmacies, it is accepted only according to the testimony, it is necessary to refer to your doctor.

Pentalgin-ICN composition

White or white pentalgin-ICN tablets with a yellowish or creamy color shade, double-screwed capsule with flat side surfaces, with risks on one side and engraving Pentalgin to another. The composition of one tablet includes:

• sodium metamizol 300 mg,
• caffeine 50 mg,
• paracetamol 300 mg,
• codeine 8 mg,
• phenobarbital 10 mg,
• auxiliary components.

Tablets can be bought 12 pieces into the contour cell packaging. 1 Packaging along with instructions for use are sold in a pack of cardboard.

pharmachologic effect

Pentalgin-ICN is a combined drug, has an analgesic, contamination and antipyretic effect.

• Paracetamol has an analgesic and antipyretic effect.
• Sodium metamizole has a pronounced analgesic effect.
• Codeine stimulates opioid receptors in various parts of the CNS, which leads to the activation of the antinocyptive system and the change in the emotional perception of pain.
• Codeine and phenobarbital increase the analgesic effect of sodium and paracetamol metamizol.
• Caffeine expands the vessels of skeletal muscles, kidneys, heart, brain.

Pentalgin-ICN increases mental and physical performance, eliminates overwork and drowsiness. The drug increases the permeability of histohematic barriers and increases the bioavailability of non-constidate analgesics, thereby promoting therapeutic effect. Also reduces the headache of vascular genesis (including migraine). Biotransformed in the liver, is excreted by the kidneys, penetrates through a placental barrier

Indications for use

Pentalgin-ICN is shown to use with a weak and moderately pronounced pain syndrome of various genesis, including with pains in joints, muscles, radiculitis, menstrual pains, neuralgias, dental and headaches (including migraine). It can be used in coldic diseases accompanied by feverish syndrome.

Contraindications

Pentalgin-ICN has the following contraindications:

• Increased sensitivity to the components of the drug
• Portal Hypertension, pronounced arterial hypertension
• Erosive-ulcerative lesions of the gastrointestinal tract (in the exacerbation phase), gastrointestinal bleeding
• Bronchial asthma, bronchospasm
• Alcoholic intoxication
• Glaucoma
• Violations of liver and kidney function
• Heavy organic diseases Cardiovascular system (including acute myocardial infarction), arrhythmia
• Brain-brain injury
• Anemia, leukopenia
• Glucose-6-phosphate dehydrogenase deficit
• Children's age up to 12 years
• Pregnancy, lactation period

With caution take with arterial hypertension easy and middle severity, in old age. Consultation is needed.

Application in pregnancy and breastfeeding: drug is contraindicated during pregnancy and during lactation. Penetrates breast milk.

Instructions for use

Pentalgin-ICN is taken inside 1 tablet 1-3 times a day. Maximum daily dose - 4 tablets. Pentalgin-ICN is not recommended to apply more than five days as an anesthetic and more than three days as antipyretic without appointing and observing the doctor.

Side effect

When using Pentalgin-ICN possible side effects:

• Allergic reactions, including Stephen-Johnson syndrome, Lyleel; bronchospasm.
• From the CNS: drowsiness, dizziness
• From the cardiovascular system: the feeling of heartbeat
• From the digestive tract: nausea, vomiting, gastralgy, hepatotoxicity, erosive-ulcerative lesions of the gastrointestinal tract
• From the Blood Organs: leukopenia, thrombocytopenia, anemia
• Causes addiction and drug addiction during long-term reception.

Overdose

Symptoms of overdose:

• nausea
• vomot
• gastralgy
• drowsiness
• tachycardia
• disturbance of heart rhythm
• foreignness of breathing
• weakness.

Treatment in overdose: induction of vomiting, washing the stomach through the probe, the appointment of adsorbents (activated carbon), symptomatic therapy aimed at maintaining vital functions.

Interaction with other medicines

The simultaneous use of Pentalgin-ICN with other non-constidium analgesics can lead to amplification of toxic effects. Sedatives and tranquilizers enhance the analgesic effect of the drug. The simultaneous use of metamizole with cyclosporin reduces the level of the latter in the blood. Barbiturates, phenylbutazone and other inductors of microsomal liver enzymes weaken the action of sodium metamizol. Tricyclic antidepressants, contraceptive agents for intake, allopurinol increase the toxicity of sodium metamizol included in the preparation.

special instructions

During treatment with the drug should be abandoned by alcohol consumption. With long-term reception (more than 5 days), it is necessary to control the pattern of peripheral blood and liver function indicators. Against the background of the use of the drug, it is possible to change the results of doping control of athletes.

In some cases, it is possible to reduce the concentration of attention and the velocity of psychomotor reactions, so during the period of treatment it is necessary to abide by the driving of vehicles and the occupation of other potentially hazardous activities that require increased concentration and speed of psychomotor reactions. Reception of the drug may make it difficult to establish a diagnosis in acute abdominal pain syndrome.

Conditions of vacation from pharmacies

Pentalgin-ICN is released from pharmacies strictly by recipe. Blank 148-1 / y-88. There is a vacation rate by 1 recipe, taking into account the indivisible packaging of 20 tablets.

Storage conditions

The drug must be stored in a dry and inaccessible place for children, at a temperature not higher than 25 C. Do not use the drug after the expiration date indicated on the package.

Analogs of the drug

Pentalgin-ICN has the following analogues:

• "Sedal-M" (Bulgaria) - Tablets №10, №20
• Sedalgin neo (Bulgaria) - Tablets №10, №20

Caffeine.

Additional components: Povidone, starch potato, calcium stearate and stearic acid.

Form release

The Pentalgin ICN is produced in the form of tablets packed in packs of 12 pieces.

pharmachologic effect

The medicine is manifested Analgesic, antipyretic and anti-inflammatory act.

Pharmacodynamics and pharmacokinetics

For this combination drug is typical anesthetic, antipyretic and anti-inflammatory action that is caused Metamizol and Naproxen .

Thanks to caffeine, the overall health of patients is improved, reduced. able to increase the effect of treatment Sodium metamizol and Paracetamol . Codeine show anti-tech action, by suppressing excitability in a cough center. Anesthetics the effect of this drug is determined by a significant excitation of opiate receptors in the peripheral tissues and the nervous system, which stimulates the antinoceceptive system and the change in emotional pain perception.

Indications for use

As a rule, Pentalgin ICN is prescribed at:

• moderately pronounced and weak pain of different origin, affecting joints, muscles, lower back region;
• menstrual pains;
• dental and ,;
• colds who are accompanied by .

Contraindications

Tablets are not prescribed at:

• sensitivity to their components;
• pronounced disorders of the liver and kidney;
• bronchospasms;
• ulcer of stomach and 12-rings;
• oppression of blood formation;
• states accompanied by the oppression of breathing;
• high intracranial pressure, brain injuries;
• acute;
• heart rate disorders;
• elevated;
• alcoholic intoxication;
• age up to 12 years;
• deficiency of glucose-6-phosphate dehydrogenase;
• , .

Side effects

Reception of tablets can lead to development, swelling of heartbeat, nausea and vomiting, bleeding disorders in the form leukopenia, granulocyptopenia or .

Instructions for the use of Pentalgin ICN tablets (method and dosage)

According to the ICN Pentalgin instructions, you can take 1 tablet no more than 3 times a day. At the same time, the daily dosage should not be more than 4 tablets.

It should be noted that this drug can be taken for anesthesia no more than 5 days, and to reduce the heat - up to 3 days. Continuing treatment more than this term is possible only after the prescription of the doctor.

Overdose

Long-term reception of tablets in elevated doses can lead to a violation of the liver and kidney work, , Reducing the velocity of psychomotor reactions. In addition, the continuous uncontrolled reception of medication in high dosages is addictive, and the presence in its composition Codeine is a drug dependence.

Usually an overdose manifests nausea, vomiting, gastralgia, arrhythmia, inhibition of the respiratory center.

Therapy includes washing the stomach, reception of intestinal adsorbents and other symptomatic treatment.

Interaction

The combination of Pentalgin-ICN with preparations that affect the nervous system can increase the oppression of the work and sedimentation of the sedative effect on the respiratory center and other systems and organs. Sodium metamizole reduces concentration , displaces oral hypoglycemic drugs from the protein , indirect anticoagulants, significantly increasing their activity. , tricyclic antidepressants, some contraceptive capable of disrupting sodium metamizole in the liver and increase its toxicity.

Simultaneous reception with other nonopioids often enhances toxic effects.

Weaken the action of metamizol sodium can barbiturates, phenylbutazon and various inductors of microsomal liver.

special instructions

If tablets are accepted for a long time, that is, more than 7 days, patients require control of the state of peripheral and liver activity.

Pentalgin-ICN reception may affect the results various analyzes Doping control in people engaged in sports.

It has been established that this medicine can make it difficult to accurately make a diagnosis in acute abdominal pain syndromes.

Treatment by this drug with atopic different forms Polinosis can lead to the development of hypersensitivity reactions.

Terms of sale

Without recipe.

Storage conditions

Tablets are stored in a dry, cool and dark place, protected from children.

Shelf life

Analogs of Pentalgin ICN.

Coincidences on the ATX 4 level code:

Such an action is characteristic of: , and Analgin.

Alcohol

The combination with alcohol often enhances the severity of side effects, as well as the effect on psychomotor reactions.

Instructions for medical application drug

Description of pharmacological action

Inhibits cyclooxygenase and inhibits the biosynthesis of PG (analgin and paracetamol), stimulates opiate receptors, activates the antinocyptive system (codeine). Inhibits (sedative effect) CNS (phenobarbital). Caffeine increases the permeability of histohematic membranes and increases the concentration of other components in the CNS.

Indications for use

Pain syndrome of various genesis of weak and medium intensity (including arthralgia, myalgia, radiculitis, algodismenae, neuralgia, headache, toothache);

Walled diseases and conditions accompanied by feverish syndrome.

Form release

pills; Packaging Contour cell 10 pack cardboard 1;

Pills; Packaging Contour cell 10 pack cardboard 2;

Pills; Packaging Contour cell 12 pack cardboard 1;

Pills; Packaging Contour cell 12 pack cardboard 2;

Pills; Packaging Contour cell 6 pack cardboard 1;

Pills; Packaging Contour cells 6 pack cardboard 2;

Pills; Packaging Contour cell 10 Cardboard box 500;

Pills; Packaging Contour Cellular 12 Cardboard Box 500;

Pills; Packaging Contour cells 6 Cardboard box 500;

Pharmacodynamics

The combined drug, has an analgesic, antipyretic, controversial action.

Paracetamol - Analgesic Antipyatik. Blocks CHA mainly in the CNS, affecting the centers of pain and thermoregulation; It has analgesic and antipyretic effect.

Sodium metamizol is an antipictic analgesic derivative of pyrazolone. It has a pronounced analgesic effect.

Caffeine is a psychostimulator, improves the well-being of patients and reduces the headache of vascular genesis (including migraine).

Phenobarbital - Barbiturate, increases the analgesic efficacy of sodium and paracetamol metamizole.

Codeine has an anesthetic effect due to the excitation of opioid receptors in various parts of the central nervous system, leading to the stimulation of the antinocyptive system and the change in the emotional perception of pain.

Pharmacokinetics

The pharmacokinetics data of Pentalgin-ICN preparation is not provided.

Use during pregnancy

Application is contraindicated during pregnancy and during lactation (breastfeeding).

Contraindications for use

Severe liver failure;
- renal failure of severe;
- bronchial asthma;
- anemia, leukopenia;
- states accompanied by oppression of breathing;
- Card-brain hypertension;
- acute myocardial infarction;
- arrhythmias;
- glaucoma;
- alcoholic intoxication;
- deficiency of glucose-6-phosphate dehydrogenase;
- Pregnancy;
- lactation period (breastfeeding);
- children's age up to 12 years;
- Increased sensitivity to the components of the drug.

With caution, the drug should be used for ulcer and duodenal ulcer in the remission phase, with arterial hypertension, in elderly patients.

Side effects

From the CNS: dizziness, drowsiness.

From the side of the cardiovascular system: heartbeat, tachycardia.

From the digestive system: nausea, vomiting, constipation.

From the side of the blood formation system: leukopenia, granulocyptopenia, agranulocytosis.

Allergic reactions: rash, itching, urticaria.

Others: With a long-term uncontrolled reception in high doses - addictive (weakening of an anesthetic effect), drug dependence (codeine), hepatic and / or renal failure.

Method of application and dose

Overdose

Symptoms: nausea, vomiting, gastralgy, tachycardia, arrhythmia, oppression of the respiratory center.

Treatment: washing the stomach, the purpose of intestinal adsorbents, if necessary, the conduct of symptomatic therapy.

Interactions with other drugs

Enhances the oppressive effect of ethanol on the CNS.

Precautions when receiving

For long use It is necessary to control the composition of peripheral blood. Avoid simultaneous alcohol intake.

Special guidelines when taking

With long-term (more than 1 week) treatment, the picture of the peripheral blood and the functional state of the liver is needed.

When taking the preparation of Pentalgin-ICN, it is possible to change the results of doping control analyzes in athletes.

Treatment of Pentalgin®-ICN makes it difficult to establish a diagnosis with acute abdominal pain syndrome.

In patients suffering from atopic bronchial asthma, half ancient, there is an increased risk of developing hypersensitivity reactions.

Impact on the ability to driving vehicles and control mechanisms

When using the drug, patients should refrain from potentially hazardous activities that require increased attention, and the speed of psychomotor reactions.

Storage conditions

List B.: In the dry, protected from light place.

Shelf life

Belonging to ATX classification:

** Drug reference is intended exclusively for informational purposes. For more more full information We ask you to refer to the annotation of the manufacturer. Do not self-medicate; Before starting the use of Pentalgin-ICN drug, you should consult a doctor. EUROLAB is not responsible for the consequences caused by the use of information posted on the portal. Any information on the site does not replace the doctor's advice and cannot serve as a guarantee of the positive effect of the drug.

Are you interested in the drug Pentalgin-ICN? Do you want to know more detailed information or do you need a doctor inspection? Or do you need an inspection? You can make an appointment to the doctor - Clinic Euro.lab always at your service! Top doctors will consider you, they will advise required help And make a diagnosis. you also can call a doctor. Clinic Euro.lab Opened for you around the clock.

** Attention! The information presented in this reference book is intended for medical professionals and should not be the basis for self-treatment. The description of the Pentalgin-ICN preparation is given to be familiarized and is not intended to appoint treatment without the participation of the doctor. Patients need a specialist consultation!

If you are interested in some other medicinal products and medicines, their descriptions and instructions for use, information about the composition and form of release, indications for use and side effects, methods of application, prices and reviews about medicinal preparations Or you have any other questions and suggestions - email us, we will definitely try to help you.